The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in HBx and/or HBsAg of Hepatitis B Virus (HBV) to treat said viral disorder； and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.
